ChEMBL ID: CHEMBL1743053
Mechanism of action: T-cell surface glycoprotein CD3 epsilon chain binding agent
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Trials and conditions connected to OTELIXIZUMAB